We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arrival | NASDAQ:ARVL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.49 | 0.50 | 0.508 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Arrival
(Name of Issuer)
Ordinary Shares, accounting value per share
(Title of Class of Securities)
L0423Q108
(CUSIP Number)
Csaba Horváth
Kinetik S.à r.l.
60A, rue des Bruyères, L-1274 Howald,
Grand Duchy of Luxembourg
+352 621 266 815
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
November 9, 2022
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are sent.
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Names of Reporting Persons. Kinetik S.à r.l. Check the Appropriate Box
if a Member of a Group (See Instructions) (a) ☐ (b) ☐ SEC Use Only Source of Funds (See
Instructions) OO Check if Disclosure of
Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐ Citizenship or Place of
Organization Luxembourg Number of Shares Beneficially Owned by Each Reporting Person With Sole Voting Power 387,997,800 Shared Voting Power 0 Sole Dispositive Power 387,997,800 Shared Dispositive Power 0 Aggregate Amount Beneficially Owned by Each Reporting Person 387,997,800 Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions) ☐ Percent of
Class Represented by Amount in Row (11) 60.78% Type of Reporting Person
(See Instructions) OO
Names of Reporting Persons. Kinetik Finance SARL Check the Appropriate Box
if a Member of a Group (See Instructions) (a) ☐ (b) ☐ SEC Use Only Source of Funds (See
Instructions) OO Check if Disclosure of
Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐ Citizenship or Place of
Organization Luxembourg Number of Shares Beneficially Owned by Each Reporting Person With Sole Voting Power 27,620,000 Shared Voting Power 0 Sole Dispositive Power 27,620,000 Shared Dispositive Power 0 Aggregate Amount Beneficially Owned by Each Reporting Person 27,620,000 Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions) ☐ Percent of
Class Represented by Amount in Row (11) 4.33% Type of Reporting Person
(See Instructions) OO
Names of Reporting Persons. The Kinetik Foundation Check the Appropriate Box
if a Member of a Group (See Instructions) (a) ☐ (b) ☐ SEC Use Only Source of Funds (See
Instructions) OO Check if Disclosure of
Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) ☐ Citizenship or Place of
Organization Guernsey Number of Shares Beneficially Owned by Each Reporting Person With Sole Voting Power 415,617,800 Shared Voting Power 0 Sole Dispositive Power 415,617,800 Shared Dispositive Power 0 Aggregate Amount Beneficially Owned by Each Reporting Person 415,617,800 Check if the Aggregate
Amount in Row (11) Excludes Certain Shares (See Instructions) ☐ Percent of
Class Represented by Amount in Row (11) 65.11% Type of Reporting Person
(See Instructions) OO
This Amendment No. 5 to the joint statement on Schedule 13D with respect to the ordinary
shares, accounting value per share (the Ordinary Shares), of Arrival, a joint stock company governed by the laws of the Grand Duchy of Luxembourg (the Issuer), filed by the Reporting Persons (as defined below)
on March 24, 2021, as amended by Amendment No. 1 to Schedule 13D filed on June 7, 2021, as amended by Amendment No. 2 to Schedule 13D filed on April 11, 2022, as amended by Amendment No. 3 to Schedule 13D filed on
July 1, 2022, and as amended by Amendment No. 4 to Schedule 13D filed on September 2, 2022 (such joint statement, as so amended and as amended herein, the Schedule 13D), amends the Schedule 13D as follows (with
capitalized terms used but not defined herein having the respective meanings given to them in the Schedule 13D): 1. Item 4 of Schedule
13D shall hereby be amended by inserting the following new paragraphs after the first paragraph thereof: On
November 9, 2022, Kinetik terminated the Plan. On November 10, 2022, Kinetik and Citigroup Global Markets Inc.
entered into a trading plan that complies with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the November 2022 Plan), a copy of which is attached hereto as
Exhibit 10. Pursuant to the November 2022 Plan, sales of up to 40,000,000 Ordinary Shares by Kinetik may be effected between November 14, 2022 and March 31, 2023 in accordance with the terms and conditions of the November 2022 Plan.
The sale of Ordinary Shares under the November 2022 Plan is subject to minimum price parameters adopted by the Reporting Persons, and there is no assurance that any Ordinary Shares will be sold under the November 2022 Plan. 2. Paragraphs (a), (b) and (c) of Item 5 of the Schedule 13D shall hereby be amended and restated in full as follows: Interest in Securities of the Issuer (a, b)The percentages of beneficial ownership reported in this Item 5, and on each Reporting Persons cover page to this
Schedule 13D, are based on a total of 638,344,885 Ordinary Shares outstanding as of September 30, 2022, as reported in the Issuers Form 6-K filed pursuant to Rule
13a-16 or 15d-16 on November 8, 2022. All of the share numbers reported below, and on each Reporting Persons cover page to this Schedule 13D, are as of
November 11, 2022, unless otherwise indicated. The cover page to this Schedule 13D for each Reporting Person is incorporated by reference in its entirety into this Item 5(a, b). Kinetik beneficially owns 387,997,800 Ordinary Shares, or approximately 60.78% of the outstanding Ordinary Shares, Kinetik
Finance beneficially owns 27,620,000 Ordinary Shares, or approximately 4.33% of the outstanding Ordinary Shares, the Foundation beneficially owns 415,617,800 Ordinary Shares, or approximately 65.11% of the outstanding Ordinary Shares, and the
Reporting Persons beneficially own, in the aggregate, 415,617,800 Ordinary Shares, or approximately 65.11% of the outstanding Ordinary Shares.
(c) Except as otherwise described in this Schedule 13D, no Reporting Person,
other than Kinetik as set forth in the table below, effected any transaction in the Ordinary Shares since August 31, 2022: Date of Sale 9/1/2022 9/2/2022 9/6/2022 9/7/2022 9/8/2022 9/9/2022 9/12/2022 9/13/2022 9/14/2022 9/16/2022 9/19/2022 The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.035 to $1.08 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.00 to $1.06 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.005 to $1.04 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.025 to $1.08 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.04 to $1.12 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.075 to $1.13 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.08 to $1.11 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.015 to $1.08 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.005 to $1.06 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.00 to $1.045 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range. The sale price reported is a weighted average price. These shares were sold in multiple transactions at prices
ranging from $1.00 to $1.02 inclusive. The reporting person undertakes to provide to the Issuer, any securities holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of
shares sold at each separate price within such range.
The sale prices do not reflect brokerage commissions paid. All such sales
were made pursuant to the Plan. 3. Item 6 of the Schedule 13D shall hereby be amended by inserting the following new paragraph after the
last paragraph thereof: The description of the November 2022 Plan in Item 4 of this Schedule 13D is incorporated by
reference into this Item 6. 4. Item 7 of the Schedule 13D shall hereby be amended by adding the following exhibit: Exhibit 10 Rule 10b5-1 Trading Plan dated November 10, 2022. 5. Except as expressly modified hereby, all provisions of the Schedule 13D shall continue in full force and effect. * * *
Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct. /s/ Csaba Horváth /s/ Gilles Dusemon /s/ Gavin Ferguson /s/ Filippo Noseda
CUSIP No. L0423Q108
13D
Page
2
of 8 Pages
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
CUSIP No. L0423Q108
13D
Page
3
of 8 Pages
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
CUSIP No. L0423Q108
13D
Page
4
of 8 Pages
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
CUSIP No. L0423Q108
Page
5
of 8 Pages
Item 5.
CUSIP No. L0423Q108
Page
6
of 8 Pages
Shares
Sold (#)
Sale Price per
Share ($)
200,000
$
1.0458
1
200,000
$
1.0236
2
200,000
$
1.0295
3
200,000
$
1.0502
4
200,000
$
1.0757
5
200,000
$
1.1003
6
200,000
$
1.0935
7
200,000
$
1.0331
8
200,000
$
1.0313
9
200,000
$
1.0196
10
38,000
$
1.0129
11
1
2
3
4
5
6
7
8
9
10
11
CUSIP No. L0423Q108
Page
7
of 8 Pages
CUSIP No. L0423Q108
Page
8
of 8 Pages
DATE: November 11, 2022
KINETIK S.À R.L.
By:
Name: Csaba Horváth
Title: Manager
KINETIK FINANCE SARL
By:
Name: Gilles Dusemon
Title: Manager
THE KINETIK FOUNDATION
By:
Name: Gavin Ferguson
Title: Councillor
By:
Name: Filippo Noseda
Title: Councillor
1 Year Arrival Chart |
1 Month Arrival Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions